News
NeoVisc®, a 1,0 % solution of highly purified Sodium Hyaluronate, used for patients with algetic, degenerative and traumatic transformation of synovial joints like knee, shoulder and hip, is available in selective countries of the Torrex Chiesi group.
This was made possible by a cooperation between Torrex Chiesi Pharma and the Canadian pharmaceutical company, Stellar Pharmaceuticals Inc., covering the coutries Austria, Czech Republic, Slovakia, Croatia, Serbia, Montenegro, Macedonia, Bosnia and Herzegowina, Poland, Hungary, Russia and the Commonwealth of Independent States (CIS).
NeoVisc® has been clinically available in Canada since 1997.
